MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1721 to 1740 of 166,322 approvalsPage 87 of 8317

Bortezomib for Injection

Approval Number: 国药准字H20253217
Registration: Jan 14, 2025

Milrinone Injection

Approval Number: 国药准字H20253214
Registration: Jan 14, 2025

Sodium Chloride Physiological Solution

Approval Number: 国药准字H20253140
Registration: Jan 14, 2025

Lactulose Oral Solution

Approval Number: 国药准字H20253168
Registration: Jan 14, 2025

Vortioxetine Hydrobromide Tablets

Approval Number: 国药准字H20253161
Registration: Jan 14, 2025

Pregabalin Capsules

Approval Number: 国药准字H20253195
Registration: Jan 14, 2025

Vecuronium Bromide for Injection

Approval Number: 国药准字H20253159
Registration: Jan 14, 2025

Famotidine Injection

Approval Number: 国药准字H20253222
Registration: Jan 14, 2025

Ceftazidime and Avibactam Sodium for Injection

Approval Number: 国药准字H20253156
Registration: Jan 14, 2025

Composite Potassium Hydrogen Phosphate Injection

Approval Number: 国药准字H20253133
Registration: Jan 14, 2025

Cefadroxil Tablets

Approval Number: 国药准字H20253136
Registration: Jan 14, 2025

Diquafosol Sodium Eye Drops

Approval Number: 国药准字H20253192
Registration: Jan 14, 2025

Rebamipide Tablets

Approval Number: 国药准字H20253187
Registration: Jan 14, 2025

Pregabalin Capsules

Approval Number: 国药准字H20253180
Registration: Jan 14, 2025

Fat Emulsion Injection(C14~24)

Approval Number: 国药准字H20253189
Registration: Jan 14, 2025

Fat Emulsion Injection(C14~24)

Approval Number: 国药准字H20253188
Registration: Jan 14, 2025

Milrinone Injection

Approval Number: 国药准字H20253215
Registration: Jan 14, 2025

Calcium Gluconate Injection

Approval Number: 国药准字H20253183
Registration: Jan 14, 2025

Prucalopride Succinate Tablets

Approval Number: 国药准字H20253129
Registration: Jan 14, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.